Page 11 - Jake Sargent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jake sargent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jake Sargent Today - Breaking & Trending Today

J&J Shot Performs Poorly Against Delta Variant


J&J Shot Performs Poorly Against Delta Variant
J&J Shot Performs Poorly Against Delta Variant
The laboratory study, released on the preprint server bioRxiv, hasn t been published in a peer-reviewed journal and focuses on one key portion of the immune response, called neutralizing antibodies.
The study examined only one aspect of protection, J&J said in an email (File)
Johnson & Johnson s single-dose Covid vaccine produced relatively low levels of antibodies against the delta variant in a study, raising questions about how well the shot will hold up against the strain that accounts for the vast majority of U.S. cases. ....

Nathaniel Landau , Jake Sargent , Rochelle Walensky , Centers For Disease , Pfizer Inc , Grossman School Of Medicine , Moderna Inc , York University , Disease Control , Prevention Director Rochelle Walensky , நத்யாநியல் ல்யாந்‌டா , ஜேக் ஸார்‌ஜெஂட் , மையங்கள் க்கு நோய் , ஃபைசர் இன்க் , மொத்த மனிதர் பள்ளி ஆஃப் மருந்து , மாடர்னா இன்க் , யார்க் பல்கலைக்கழகம் , நோய் கட்டுப்பாடு ,

J&J shot raises fewer antibodies against Delta variant in study


(July 21): Johnson & Johnson’s single-dose Covid vaccine produced relatively low levels of antibodies against the delta variant in a study, raising questions about how well the shot will hold up against the strain that accounts for the vast majority of U.S. cases.
The laboratory study, released on the preprint server bioRxiv, hasn’t been published in a peer-reviewed journal and focuses on one key portion of the immune response, called neutralizing antibodies. New York University scientists found that J&J’s vaccine produced roughly five-fold lower levels of the protective antibodies against the delta variant compared to the levels raised against an early coronavirus strain. ....

Nathaniel Landau , Jake Sargent , Rochelle Walensky , Centers For Disease , Pfizer Inc , Grossman School Of Medicine , Moderna Inc , York University , Disease Control , Prevention Director Rochelle Walensky , நத்யாநியல் ல்யாந்‌டா , ஜேக் ஸார்‌ஜெஂட் , மையங்கள் க்கு நோய் , ஃபைசர் இன்க் , மொத்த மனிதர் பள்ளி ஆஃப் மருந்து , மாடர்னா இன்க் , யார்க் பல்கலைக்கழகம் , நோய் கட்டுப்பாடு ,

First opioid jury trial marks high-stakes test for drug industry


Jurors on Long Island are set to determine whether a group of opioid makers and drug distributors created a public health crisis and should pay for it, in a bellwether trial for lawsuits filed by communities across the U.S.
Endo International, Teva Pharmaceutical Industries and McKesson are among the companies that New York Attorney General Letitia James and Nassau and Suffolk counties say made billions of dollars selling the highly addictive pills while illegally marketing them or turning a blind eye to suspiciously large orders.
Opening arguments in the Central Islip trial are scheduled to start Tuesday.
The stakes are high for the industry. ....

United States , New York , Suffolk County , Central Islip , New Providence , Nassau County , Long Island , West Virginia , Elizabeth Burch , Richard Ausness , Victor Ciappa , Jerry Garguilo , Jake Sargent , Daniel Busby , Holly Froum , Jeffrey Reynolds , Letitia James , Walgreens Boots Alliance , Rite Aid , University Of Georgia , Children Association , Cardinal Health , Endo International , Fiscal Policy Institute , Teva Pharmaceutical Industries , University Of Kentucky ,